| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Metabolic Research Unit and the Department of Medicine, University of California San Francisco, California 94143
Address all correspondence and requests for reprints to: J. Blake Tyrrell, M.D., Metabolic Research Unit, 1141-HSW, University of California, San Francisco, California 94143.
To more conveniently assess dynamic changes in the biologically active fraction of cortisol, we measured cortisol in 1-h urine samples obtained from 0700–0800 and from 2200–2300 h. In 20 normal subjects, morning 1-h urinary cortisol levels were 78 ± 36 ng/mg creatinine (mean ± SD), whereas levels from 2200-2300 h were 22 ± 12 ng/mg creatinine, demonstrating diurnal variability. In 14 patients with Cushing's syndrome, mean morning urinary cortisol was elevated (207 ± 176 ng/mg creatinine), but there was overlap with values in normal subjects. In contrast, evening values in Cushing's syndrome (248 ± 208 ng/mg creatinine) were elevated in each patient; there was no diurnal variation and no overlap with normal subjects. Similarly, the morning urinary cortisol response to dexamethasone (1 mg, orally, at 2300 h) clearly separated normal subjects from those with Cushing's syndrome (5 ± 6 vs. 169 ± 149 ng/mg creatinine, respectively). In 10 patients with secondary hypoadrenalism, urinary cortisol levels were less than 2 ng/mg creatinine in both morning and evening 1-h samples. Thus, the determination of cortisol in 1-h samples is a practical and simple method of assessing cortisol secretion and allows multiple sampling without hospitalization. It is effective in assessing dynamic cortisol responses, such as diurnal variation and responsiveness to suppression, and it is an effective screening test for Cushing's syndrome and hypoadrenalism.
Received September 17, 1985.
This article has been cited by other articles:
![]() |
A. W. Meikle, J. Findling, M. M. Kushnir, A. L. Rockwood, G. J. Nelson, and A. H. Terry Pseudo-Cushing Syndrome Caused by Fenofibrate Interference with Urinary Cortisol Assayed by High-Performance Liquid Chromatography J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3521 - 3524. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Castro, P. C. L. Elias, A. R. P. Quidute, F. P. B. Halah, and A. C. Moreira Out-Patient Screening for Cushing's Syndrome: The Sensitivity of the Combination of Circadian Rhythm and Overnight Dexamethasone Suppression Salivary Cortisol Tests J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 878 - 882. [Abstract] [Full Text] |
||||
![]() |
J. Newell-Price, P. Trainer, M. Besser, and A. Grossman The Diagnosis and Differential Diagnosis of Cushing's Syndrome and Pseudo-Cushing's States Endocr. Rev., October 1, 1998; 19(5): 647 - 672. [Abstract] [Full Text] |
||||
![]() |
H. Raff, J. L. Raff, and J. W. Findling Late-Night Salivary Cortisol as a Screening Test for Cushing's Syndrome J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2681 - 2686. [Abstract] [Full Text] |
||||
![]() |
T. B. Kaye and L. Crapo The Cushing Syndrome: An Update on Diagnostic Tests Ann Intern Med, March 15, 1990; 112(6): 434 - 444. [Abstract] [PDF] |
||||
![]() |
A. P. Zis, R. A. Remick, B. E. K. Grant, M. Bernstein, and A. Grant The Evening Urine Cortisol Excretion Test in Depression Arch Gen Psychiatry, October 1, 1987; 44(10): 919 - 920. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |